Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX)
Clinical trial NCT00278889 · COMPLETED
Trial details
- NCT number
- NCT00278889
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2007-11-01
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.